Insmed, Inc.
INSM Healthcare Biotechnology
Insmed, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $606.4 million, up 66.7% from fiscal 2024.
- Revenue
- +268.4%
- EPS
- +73.8%
- Free cash flow
- +81.1%
- Total debt
- +0.27%
Quarter to September 2026, against a year earlier
Follow INSM
Alert me
Insmed, Inc. (INSM) Book value per share
Insmed, Inc.'s book value per share at the end of fiscal 2025 was 3.7×, up 113.4% from 1.7× in fiscal 2024. At the end of the quarter to 30 September 2026 it was 3.3×. Over the past ten years it has ranged from −2.4× (fiscal 2023) to 5.4× (fiscal 2017); the current reading is higher than 82% of that period. Insmed, Inc. ranks 204th of 611 Biotechnology companies by book value per share.
Book value per share, annual
Embed this chart
Annual newest first
| Period | Book value per share | Change |
|---|---|---|
| FY2025 | 3.7× | 113.44% |
| FY2024 | 1.7× | — |
| FY2023 | −2.4× | — |
| FY2022 | 0.7× | (80.48%) |
| FY2021 | 3.7× | 29.53% |
| FY2020 | 2.8× | (8.66%) |
| FY2019 | 3.1× | 14.24% |
| FY2018 | 2.7× | (50.05%) |
| FY2017 | 5.4× | 117.28% |
| FY2016 | 2.5× | (53.05%) |
Quarterly newest first
| Period | Book value per share | Change |
|---|---|---|
| Sep 2026 | 3.3× | (4.76%) |
| Jun 2026 | 3.5× | 6.54% |
| Mar 2026 | 3.3× | (11.90%) |
| Dec 2025 | 3.7× | (16.84%) |
| 43 more quarters | Free account |
Against its own ten years
Book value per share against peers
| Company | Book value per share |
|---|---|
| BNTX BioNTech SE Sponsored ADR compare | 81.8× |
| INCY Incyte Corporation compare | 27.8× |
| ALNY Alnylam Pharmaceuticals, Inc. compare | 26.9× |
| ASND Ascendis Pharma A/S compare | 26.0× |
| GMAB Genmab A/S Sponsored ADR compare | 9.7× |
| EXEL Exelixis, Inc. compare | 7.4× |
| ROIV Roivant Sciences Ltd. compare | 6.8× |
| INSM Insmed, Inc. | 3.3× |
| BBIO BridgeBio Pharma, Inc. compare | −8.4× |
What Book value per share is
BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.
(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))
More on INSM
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement